Application 090194
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 20MG/10ML (2MG/ML) | No | No |
| 002 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 150MG/30ML (5MG/ML) | No | No |
| 003 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 150MG/20ML (7.5MG/ML) | No | No |
| 004 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 100MG/10ML (10MG/ML) | No | No |
| 005 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 40MG/20ML (2MG/ML) | No | No |
| 006 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLUTION;INJECTION | 200MG/20ML (10MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090194-001 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | ||
| A090194-002 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | ||
| A090194-003 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | ||
| A090194-004 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | ||
| A090194-005 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | ||
| A090194-006 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090194-001 | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090194-002 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090194-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090194-004 | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090194-005 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090194-006 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090194-001 | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090194-002 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090194-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090194-004 | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090194-005 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090194-006 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090194-001 | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090194-002 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090194-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090194-004 | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090194-005 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090194-006 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090194-001 | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090194-002 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090194-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090194-004 | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090194-005 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090194-006 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090194-001 | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090194-002 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090194-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090194-004 | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090194-005 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090194-006 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090194-001 | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090194-002 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090194-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090194-004 | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090194-005 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090194-006 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090194-001 | ROPIVACAINE HYDROCHLORIDE | 20MG/10ML (2MG/ML) | SOLUTION / INJECTION | 2014-09-23 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090194-002 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090194-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/20ML (7.5MG/ML) | SOLUTION / INJECTION | 2014-09-23 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090194-004 | ROPIVACAINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INJECTION | 2014-09-23 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-31 18:47 UTC | 2024-05 | A090194-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A090194-002 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A090194-003 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A090194-004 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A090194-005 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A090194-006 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090194-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090194-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090194-003 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090194-004 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090194-005 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090194-006 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A090194-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A090194-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A090194-003 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A090194-004 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A090194-005 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A090194-006 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A090194-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A090194-002 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A090194-003 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A090194-004 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A090194-005 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A090194-006 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A090194-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090194-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090194-003 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090194-004 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090194-005 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A090194-006 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A090194-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A090194-002 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A090194-003 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A090194-004 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A090194-005 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A090194-006 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A090194-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A090194-002 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A090194-003 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A090194-004 | AP | 1 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7 | 2024-08-15 | Warnings, Adverse reactions | ROPIVACAINE HYDROCHLORIDE |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 23d2d448-a744-4877-9f2d-7e57c198da89 | 2024-08-06 | Warnings, Adverse reactions | ROPIVACAINE HYDROCHLORIDE |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c6613708-c1f7-4f5c-91a3-ebbc1d7905c6 | 2024-07-10 | Warnings, Adverse reactions | ROPIVACAINE HYDROCHLORIDE |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 56dfabf7-f7a8-4601-b17a-cb16fb995b0f | 2024-05-22 | Warnings, Adverse reactions | ROPIVACAINE HYDROCHLORIDE |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Amneal Pharmaceuticals LLC | da1ce22b-6a8e-40a2-afbb-011fa3ed3a8b | 2024-04-18 | Warnings, Adverse reactions | Ropivacaine Hydrochloride ROPIVACAINE HYDROCHLORIDE |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | Baxter Healthcare Corporation | e057aeb2-5125-490c-b691-847426fd42d0 | 2023-10-10 | Warnings, Adverse reactions | ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | Baxter Healthcare Corporation | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 2023-06-28 | Warnings, Adverse reactions | ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE |
| Ropivacaine hydrochloride | ROPIVACAINE HYDROCHLORIDE | Gland Pharma Limited | 643c1729-096e-459c-80c1-78b78e698da6 | 2022-08-22 | Warnings, Adverse reactions | Ropivacaine hydrochloride ROPIVACAINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-9300 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9300 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9300 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9300 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9300 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9301 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9301 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9301 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9301 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9301 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9302 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9302 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9302 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9302 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9302 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9303 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9303 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9303 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9303 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-9303 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |